As no specific treatments exist for RYR1-related myopathies, it was decided to test whether NAC could decrease oxidative stress and increase muscle endurance in those patients in a phase1/2 clinical study (ClinicalTrials.gov Identifier: NCT02362425). This evidence concerns the gene RYR1 and myopathy.